189 related articles for article (PubMed ID: 24704529)
1. Genetics of rare mesenchymal tumors: implications for targeted treatment in DFSP, ASPS, CCS, GCTB and PEComa.
Rutkowski P; Przybył J; Świtaj T
Int J Biochem Cell Biol; 2014 Aug; 53():466-74. PubMed ID: 24704529
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapies in rare sarcomas: IMT, ASPS, SFT, PEComa, and CCS.
Stacchiotti S; Marrari A; Dei Tos AP; Casali PG
Hematol Oncol Clin North Am; 2013 Oct; 27(5):1049-61. PubMed ID: 24093175
[TBL] [Abstract][Full Text] [Related]
3. Malignant melanotic Xp11 neoplasms exhibit a clinicopathologic spectrum and gene expression profiling akin to alveolar soft part sarcoma: a proposal for reclassification.
Wang XT; Fang R; Zhang RS; Ye SB; Li R; Wang X; Pan R; Liu C; Chen JY; Zhao M; Teng XD; Yu WJ; Li YJ; Wang FH; Zhang JG; Yang QC; Zhang YS; Lu ZF; Ma HH; Zhou XJ; Xia QY; Rao Q
J Pathol; 2020 Aug; 251(4):365-377. PubMed ID: 32418203
[TBL] [Abstract][Full Text] [Related]
4. Malignant perivascular epithelioid cell tumor of the oropharynx with strong TFE3 expression mimicking alveolar soft part sarcoma: a case report and review of the literature.
Saluja K; Thomas J; Zhang S; Sturgis EM; Jain KS; Prieto VG; El-Naggar AK; Bell D
Hum Pathol; 2018 Jun; 76():149-155. PubMed ID: 29208563
[TBL] [Abstract][Full Text] [Related]
5. PEComa with ASPSCR1::TFE3 fusion: expanding the molecular genetic spectrum of TFE3-rearranged PEComa with an emphasis on overlap with alveolar soft part sarcoma.
Zhao M; Huang Y; Yin X; Xu J; Sun Y; Wang J
Histopathology; 2024 Feb; 84(3):482-491. PubMed ID: 37936565
[TBL] [Abstract][Full Text] [Related]
6. [Molecular biology of sarcoma and therapeutic choices].
Dufresne A; Cassier P; Heudel P; Pissaloux D; Wang Q; Blay JY; Ray-Coquard I
Bull Cancer; 2015 Jan; 102(1):6-16. PubMed ID: 25609490
[TBL] [Abstract][Full Text] [Related]
7. Is immunohistochemistry always the panacea to morphologic mimics? Two, distinct soft tissue tumors exhibiting alveolar pattern and TFE3 immunoreactivity.
Shah A; Rekhi B; Patil A
Indian J Pathol Microbiol; 2021; 64(4):767-770. PubMed ID: 34673600
[TBL] [Abstract][Full Text] [Related]
8. Review of the medical literature and assessment of current utilization patterns regarding the use of two common fluorescence in situ hybridization assays in the diagnosis of dermatofibrosarcoma protuberans and clear cell sarcoma.
Linos K; Kozel JA; Hurley MY; Andea AA
J Cutan Pathol; 2018 Dec; 45(12):905-913. PubMed ID: 30155908
[TBL] [Abstract][Full Text] [Related]
9. Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues.
Fanburg-Smith JC; Miettinen M
Hum Pathol; 2001 Sep; 32(9):976-83. PubMed ID: 11567228
[TBL] [Abstract][Full Text] [Related]
10. Biologic Activity of Autologous, Granulocyte-Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines.
Goldberg JM; Fisher DE; Demetri GD; Neuberg D; Allsop SA; Fonseca C; Nakazaki Y; Nemer D; Raut CP; George S; Morgan JA; Wagner AJ; Freeman GJ; Ritz J; Lezcano C; Mihm M; Canning C; Hodi FS; Dranoff G
Clin Cancer Res; 2015 Jul; 21(14):3178-86. PubMed ID: 25805798
[TBL] [Abstract][Full Text] [Related]
11. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
[TBL] [Abstract][Full Text] [Related]
12. MUM-1 expression differentiates tumors in the PEComa family from clear cell sarcoma and melanoma.
Ferenczi K; Lastra RR; Farkas T; Elenitsas R; Xu X; Roberts S; Brooks JS; Zhang PJ
Int J Surg Pathol; 2012 Feb; 20(1):29-36. PubMed ID: 21903680
[TBL] [Abstract][Full Text] [Related]
13. Paediatric and adolescent alveolar soft part sarcoma: A joint series from European cooperative groups.
Orbach D; Brennan B; Casanova M; Bergeron C; Mosseri V; Francotte N; Van Noesel M; Rey A; Bisogno G; Pierron G; Ferrari A
Pediatr Blood Cancer; 2013 Nov; 60(11):1826-32. PubMed ID: 23857870
[TBL] [Abstract][Full Text] [Related]
14. Advances in the management of alveolar soft part sarcoma.
O'Sullivan Coyne G; Naqash AR; Sankaran H; Chen AP
Curr Probl Cancer; 2021 Aug; 45(4):100775. PubMed ID: 34284873
[TBL] [Abstract][Full Text] [Related]
15. Malignant perivascular epithelioid cell neoplasm (PEComa) of the urinary bladder with TFE3 gene rearrangement: clinicopathologic, immunohistochemical, and molecular features.
Williamson SR; Bunde PJ; Montironi R; Lopez-Beltran A; Zhang S; Wang M; Maclennan GT; Cheng L
Am J Surg Pathol; 2013 Oct; 37(10):1619-26. PubMed ID: 23797724
[TBL] [Abstract][Full Text] [Related]
16. The role of molecular testing in the diagnosis of cutaneous soft tissue tumors.
Cheah AL; Billings SD
Semin Cutan Med Surg; 2012 Dec; 31(4):221-33. PubMed ID: 23174492
[TBL] [Abstract][Full Text] [Related]
17. Molecular Landscape in Alveolar Soft Part Sarcoma: Implications for Molecular Targeted Therapy.
Soheilifar MH; Taheri RA; Zolfaghari Emameh R; Moshtaghian A; Kooshki H; Motie MR
Biomed Pharmacother; 2018 Jul; 103():889-896. PubMed ID: 29710505
[TBL] [Abstract][Full Text] [Related]
18. Polypoid PEComa in the rectum of a 15-year-old girl: case report and review of PEComa in the gastrointestinal tract.
Ryan P; Nguyen VH; Gholoum S; Carpineta L; Abish S; Ahmed NN; Laberge JM; Riddell RH
Am J Surg Pathol; 2009 Mar; 33(3):475-82. PubMed ID: 19092636
[TBL] [Abstract][Full Text] [Related]
19. Update on the imaging of malignant perivascular epithelioid cell tumors (PEComas).
Phillips CH; Keraliya AR; Shinagare AB; Ramaiya NH; Tirumani SH
Abdom Radiol (NY); 2016 Feb; 41(2):368-76. PubMed ID: 26867923
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapies for sarcomas: new roles for the pathologist.
Al-Zaid T; Somaiah N; Lazar AJ
Histopathology; 2014 Jan; 64(1):119-33. PubMed ID: 24117526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
